Available exclusively from Resilience, Sprout Solutions™ helps nurture your drug substance from a small sprout all the way to market, giving you a transparent, partnership-minded provider who’s with you every step of the way.
Auto-T™
The Auto-T cell therapy manufacturing platform from Resilience offers therapeutic innovators a vetted and accelerated pathway to clinical trials. Auto-T is an end-to-end manufacturing and assay platform for LVV-based autologous CAR-T and TCR-T cell therapies containing all required regulatory support to get your clinical trial started within one year of signing on
Idea to Clinic™
Getting you from ideation to clinic in record time demands a simultaneous focus on big data and small details. That’s precisely where Idea to Clinic™ comes in. It puts our processes and technologies to work at achieving a considerable ambition: to deliver your team a 30% time savings from start to finish.
SNAPLVV™
Get the right amount of lentivirus vector (LVV) just the way you need it – fast and easy. Enter SnapLVV™ — an off-the-shelf process to get your cell therapy ready for first-in-human studies without time-consuming de novo development. You plug, play, and get a single batch of material that gives you everything you need to get through your Phase I studies.
